Outpace Bio expands cell therapy R&D, nets research collaborations in Seattle

Outpace Bio, a Seattle-based biotech that aims to create cell therapies, has cemented its presence in the Emerald City with a new facility and a pair of local research partnerships with scientific leaders. The biotech announced Tuesday that it secured a new facility in a 23,000-square-foot space in Seattle’s Dexter…

Click here to view original post